Literature DB >> 33819934

Revision Surgeries at the Index Level After Cervical Disc Arthroplasty - A Systematic Review.

Andrei Fernandes Joaquim1, Nathan J Lee2, K Daniel Riew2.   

Abstract

OBJECTIVE: To perform a systematic literature review on revision surgeries at the index level after cervical disc arthroplasty (CDA) failure.
METHODS: A systematic literature review was performed according to the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines. Prospective studies on patients who required a secondary surgery after CDA failure were included for analysis. The minimum follow-up for these studies was 5 years.
RESULTS: Out of 864 studies in the original search group, a total of 20 studies were included. From a total of 4,087 patients, 161 patients required a reoperation at the index level. A total of 170 surgeries were performed, as some patients required multiple surgeries. The most common secondary procedures were anterior cervical discectomy and fusion (ACDF) (68%, N = 61) and posterior cervical fusion (15.5%, N = 14), followed by other reoperation (13.3%, N = 12). The associated outcomes for those who required a revision surgery were rarely mentioned in the included literature.
CONCLUSION: The long-term revision rate at the index level of failed CDA surgery was 3.9%, with a minimum 5-year follow-up. ACDF was the most commonly performed procedure to salvage a failed CDA. Some patients who required a new surgery after CDA failure may require a more extensive salvage procedure and even subsequent surgeries.

Entities:  

Keywords:  Anterior cervical disc replacement; Cervical arthroplasty; Index level; Reoperations; Revision

Year:  2021        PMID: 33819934      PMCID: PMC8021828          DOI: 10.14245/ns.2040454.227

Source DB:  PubMed          Journal:  Neurospine        ISSN: 2586-6591


INTRODUCTION

Cervical disc arthroplasty (CDA) is well-acknowledged as a motion-sparing alternative to treat mild cervical degenerative disease [1]. In comparison to anterior cervical discectomy and fusion (ACDF), CDA can achieve comparable patient-reported and clinical outcomes [2,3]. Specifically, several studies have shown that CDA can improve postoperative cervical range of motion and lower the risk of adjacent segment disease [2,3]. However, to our knowledge, there is no systematic review detailing how surgeons are managing patients when CDA fails. The reported revision rate after CDA varies widely in the literature. Although many of the randomized trials reported a low rate of secondary surgeries after CDA, as high as 15% of reoperations were documented in retrospective studies, which may due to different indications for revisions as well as differences in CDA [4,5]. Additionally, due to the lack of clear definitions for failure, such as the term revision used interchangeably for replacing a new implant, reposition of a dislocated device or even removal and then performing an ACDF, for instance, it is difficult to evaluate the characteristics of revisions after a CDA, as well as the outcome of these patients. To address the limitations, this systematic review focuses on revision surgery after CDA. The purpose of our review is to provide a comprehensive assessment on the existing literature on the underlying reasons for CDA failure, the types of secondary procedures performed, and the associated outcomes of revision surgery.

MATERIALS AND METHODS

We performed a systematic literature review to evaluate revision surgeries after CDA. This systematic review followed the guidance of PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) [6]. The PEO frameworks used in this review were as follows: Patients: with degenerative cervical disc disease requiring surgical treatment; Exposure: cervical arthroplasty requiring a new surgical intervention at the index treated level; Outcomes: type of secondary intervention, number of reoperations, outcomes.

1. Search Strategy

We reviewed PubMed for randomized controlled trials or prospective cohort studies that reported data on causes and outcome after a revision surgery for CDA. All existing studies up until April 26, 2020, were queried and reviewed. We searched for studies from the reference list of included studies and other relevant data in addition to potentially eligible studies. The first search was performed using the following keywords: “cervical arthroplasty prospective” with 864 studies. The second search was performed using the following keywords: “cervical disc arthroplasty” with 59 studies. All titles and abstracts were screened. A flow chart detailing our search selection can be seen in Fig. 1.
Fig. 1.

Flow chart diagram of our search mechanism in accordance to the PRISMA. PubMed research September 26, 2022; first search - “cervical arthroplasty prospective” – 864 articles and second search - “revision cervical disc arthroplasty – 59 articles.

1) Methodological quality evaluation

All the studies were analyzed for internal validity integrity and graded for level of evidence in accordance to the Oxford Centre for Evidence-based medicine [7].

2) Eligibility criteria

Prospective studies with a minimum follow-up of 5 years. Studies focused on patients who underwent a CDA; studies in English language; studies reporting secondary surgeries at the index level after a CDA (revision, removal, redo, explant, etc.).

2. Data Collection Process

One (AFJ) of the authors independently extracted data from the included studies using a piloted data extracted form, resolving any discrepancies through discussion with the others. The references of relevant studies were cross-checked for additional studies not identified by the electronic search.

3. Data Extraction

The following data were extracted from the included studies: number of patients, study design, follow-up period, number of revisions surgeries, and details of subsequent surgeries followed a CDA were evaluated (e.g., index vs. adjacent vs. nonadjacent levels, type of revision), and associated outcomes after revision surgery.

RESULTS

1. Study Selection

A total of 20 studies were included. There were 10 prospective randomized multicenter studies (level 1 of evidence), 3 prospective randomized single-center studies (level 1 of evidence), and 7 prospective cohort studies (level 2 of evidence). A total of 4,087 patients were included [8-27]. Follow-up rates, when documented, varied from 54% to 92%, with the exception of the study by Walraevens et al. [8] which had only 26 of 89 patients with a follow-up at 8 years (29.2%). All the information extracted from the studies are summarized in Table 1 [8-27].
Table 1.

Summary of all the data extracted from the 20 included studies

StudyStudy design and deviceNo. of patients initially treated with CDARevisions surgeries at index level, at any other level or nonspecifiedProcedure for revision the index level failureComplicationsObservations
Walraevens et al. [8], 2010Prospective cohort study single center89 Patients4-Year follow-up – 2 reoperated at an adjacent level (excluded)Heterotopic ossification at: 4 years – 66% HO free and 5% grade 4, 6 years – 62% HO free and 8% grade 4, 8 years – 61% HO free and 8% grade 4
Bryan4- to 6-year follow up – 1 reoperated at the index level and 2 at an adjacent level (3 excluded)
1 Patient operated at the index levelSubsidence: 0.69±4.5 mm at 4 years; 0.72±0.59 mm at 6 years and 0.77±0.69 mm at 8 years
4 Operated on at an adjacent level
Aghayev et al. [9], 2013Prospective multicenter observational case series332 PatientsIntraoperative complication 0.6%. Two patients (0.6%) required early surgery for implant removal and fusion and hematoma evaluation.2 ACDF37 (11%) Had ASD progression – 35 had one segment treated and 2 had 2 segments treatedAt 5 years of follow-up 40.7% had osteophytes affecting range of motion
Bryan
Prestige
Discocerv12 (3.6%) Patients had early reintervention not specified.15 Patients (4.6%) had a progression of distant segment degeneration – 14 with a monosegmental surgery and 1 with a bisegmental surgery – 7 were cranially and 9 caudally to the treated level
Scient’x
Moby-CEarly postoperative complication 7.2%
LDR Medical
ProDisc-C
Hacker et al. [10], 2013Prospective single site randomized clinical trial28 Patients (Bryan)+4 additional patients5 Patients had symptoms attributed to the CDA – 4 Bryan (2 patients beyond 4 years of follow-up and 2 beyond 5 years) and 1 Prestige (after 4 years of follow-up).3 ACDF1 ACCF1 PCF2 Other Bryan with neck pain treated without surgery – haloing about their devices – 1 case 1 year later with resolution of the haloing and improvement and the other lost follow-up.
Bryan19 Patients (Prestige LP)2 Bryan – surgical revision – 1 for device subluxation and subtle findings of myelopathy than an ACDF was performed – outcome was fair. 1 for kyphosis and bone deformity requiring a two level ACDF with a good outcome.
Prestige LP1 Prestige case had neck and arm pain with loss of vertebral body height and deformity, with HO.
Device was removed with a 2 level fusion and minimal improvement. After that a third procedure was required for graft subsided, with kyphosis, corpectomy then posterior fusion – a fair outcome was reported.
Zigler et al. [11], 2013Prospective randomized multicenter study103 Patients2.9% of secondary surgeries at 5 years (3 at the index level due to ongoing pain without implant failures)Implanted related adverse effects reported for 1%
ProDisc-C11.7% of surgery-related adverse events (dysphagia, edema, dural tear, etc.)
Burkus et al. [12], 2014Prospective randomized multicenter study276 Patients11 Patients (4.8%) had secondary surgeries at the index level.8 ACDFSubsidence 12/165 patients at 60 months and 7 (4.2%) of 166 patients at 84 months
PrestigeNo revision surgery for adjust or modify the original implant configuration1 Patient had disc implant migration (0.5%) at the 84-month evaluation.
8 Nonelective implant removals with an interbody fusion because of persistent radicular pain5 Patients (2.4%) had a broken or fractured Prestige screw
11 Patients (4.6%) had a second surgery involved adjacent levels.
Janssen et al. [13], 2015Prospective randomized multicenter study103 Initially but 86 patients were followed7 Secondary surgeries – 7%, 6 at the index level – 5 with device removal and fusion and 1 involved a foraminotomy and posterior cervical fusion with the ProDisc left in place.5 ACDF41 Adverse events in 28 (27%) of the 103 patients – neck pain that was the most common
ProDisc-C1 PCF+ foraminotomy
Gornet et al. [14], 2016Prospective nonrandomized multicenter study280 PatientsCumulative rate of secondary surgery was 9.6% at the index and adjacent level.14 ACDF17.5% of adverse effects related to device and surgical device surgical procedure related events, with 6.1% of serious adverse effects secondary to device13% of HO at 84 months
Prestige LPThere were 23 additional procedures: 1 revision, 14 removal, 4 supplemental fixation and 3 reoperations.4 Revision/reoperations
2-levels4 Supplemental fixation
Hisey et al. [15], 2016Prospective randomized multicenter study164 Patients8 Patients (4.9%) had a subsequent surgery1 LaminectomyRadiographic failure (defined as spontaneous fusion with radiographic evidence of bridging bone across the disc space and less than 2° of angular motion on flexion/extension) occurred in 5.5% of the patientsReasons for fusion at the index level: oversized implant, development of heterotopic ossification causing pain and kyphosis due to malpositioned device
Mobi-C1 Patient had a laminectomy at the index level, 4 cases had a fusion and removal of the implant (2 of these 4 had also a third surgery to revise the ACDF). Finally, 3 patients (1.83%) had surgery at the adjacent level.4 ACDF
Jackson et al. [16], 2016Prospective randomized multicenter clinical trial260 Patients 1 level4.5% Subsequent surgery for 1-level2 ACDFSome patients required multiple subsequent surgeries: 1 had a TDR removed than an ACDF at the index level, and finally a three level fusion.
Mobi-C234 patients 2 levels7.3% Subsequent surgery for 2-level1 ACDF + posterior fusion1 Had a TDR removed then 2 level fusion and finally a revision fusion with foraminal decompression
One or 2 levels3.4% (6/179) Revision at the index level 1-level group1 Patient had removal of the 2 TDR with a fusion, requiring an anterior fusion followed by a combined fusion later
4.7% (11/234) Revision at the index level 2-level group1 Patient had a TDR removed after a motor vehicle accident
Radcliff et al. [17], 2016Prospective randomized multicenter study225 Patients16 Secondary surgeries (7.1%, 16/225) – 9/225 (4%) in the index level and 7/225 (3.1%) at adjacent levels10 Patients (4.4%) had potentially devicerelated serious adverse events – with 4 cases of implant malposition
Mobi-C
Dejaegher et al. [18], 2017Prospective cohort study single center89 Patients7 Patients (8%) had 8 additional spine surgery to treat persistent symptoms – 6 radiculopathy and 1 myelopathy – 2 (2%) at the index level and 5 (6%) at an adjacent levels21 Patients (24%) had new or recurrent radiculopathy or myelopathy
Bryan14 Patients treated non-surgically for pain – 12 solved and 2 were symptomatic but did not have a new procedure186 Adverse effects during follow-up in 73 patients – 34% pain problems (neck, shoulder or arm), 25% pain in the hip, leg, knee or low back.
2nd surgery at the index level – 2 patients had their prosthesis removed.
Adjacent level surgery – 3 patients had a 2nd Bryan implanted, one of them receiving a later laminoforaminotomy later.
2 Patients had a fusion due to bridging osteophytosis and kyphosis.
Lanman et al. [19], 2017Prospective randomized multicenter study209 Patients4.2% of secondary surgeries at the index level (8 patients 10 surgeries) – one removal after 40 days postoperatively due to arm pain and the other at 1.3 years due to cervical kyphosis. Other removals between 1.7 to 4.5 years due to foraminal stenosis, degenerative changes (2 cases), failed arthroplasty and loosening of hardware after a motor vehicle accident8 ACDF3.2% of serious adverse effects (grade 3 or 4) – implant or surgical procedure associated
Prestige LP 2-levels6.5% of second surgeries at adjacent levels11.9% of grade IV HO
Mehren et al. [20], 2017Prospective cohort study50 Patients 27 (57.4%) 1 level; 17 (36.2%) 2 levels, and 3 (6.4%) with 3 levelsNo surgery for symptomatic adjacent level2 ACDFNo prosthesis dislocationsHO at 10 years: grade 0, 10%; grade 1, 10%; grade 2, 22%; grade 3, 32%, and grade 4, 26%
ProDisc CThree patients underwent spine infiltrations for neck pain.One case – significant subsidence after a motor vehicle accident (non-operative management)
Two patients required a fusion due to intraoperative fractures of the posterior vertebral wall and 1 patient was reoperated one year after surgery due to neck pain.13 (35.7%) of adjacent segment degeneration (10 cranial and 3 below the index level)
Radcliff et al. [21], 2017Prospective randomized multicenter study164 Patients (1 level)1 Level: subsequent surgeries at the index level was 3% (5/164 – 4 removal, 1 reoperation) for persistent radiculopathy and neck pain (3)9 ACDF5.3% (12/225) of patients had adverse events for 2-level and 6.1% (10/164) for one level.A bridging bone at either level was presented in 11.1% (12/108) of patients for 1-level
Mobi-C225 Patients (2 levels)1 Malpositioned implant required additional surgery5 ReoperationA bridging bone at either level was presented in 11.1% of patients for 2 levels
1 Gross motion due to over distraction and oversized implant requiring a fusion1 Supplemental fixation1 Level: 40.4% of ASD in the superior level and 43.8% in the inferior level
3.7% (6/164) Required surgery for at least one adjacent level2 Levels: 37.5% of ASD in the superior level and 30.3% in the inferior level
2 Levels: subsequent surgeries at the index level was 4.4% (10/225 – 5 removal, 2 reoperation, 2 revision, and 1 supplemental fixation) for persistent radiculopathy and neck pain (7), and 4.4% (10/225) at the adjacent level.
Sasso et al. [22], 2017Prospective randomized singlecenter study22 Patients9% (2 patients) Required reoperation – one at an adjacent level and a second at a nonadjacent level (ACDF used for both)2 ACDFNo details of complicationsThree patient were converted intraoperatively to an ACDF – severe disc degeneration, small disc space and inadequate visualization of the index level (C67)
Bryan
Coric et al. [23], 2018Prospective randomized multicenter study136 Patients8% of revision surgeries at the index level (11 patients)1.4% Device migrationNo details of outcome after reoperations or details of the technique used for reoperation
MoM TDR7 Patients (5.1%) – device related1.4% Subsidence
Kineflex C4 Patients (3%) probably device related14.3% of radiolucency
HO with a bridging across the disc space in 2.9% of the cases
Vaccaro et al. [24], 2018Prospective nonrandomized and randomized multicenter study89 Patients nonrandomized and 151 randomized patients10 Surgeries at the index level (4.2%) at 7 years postoperative – 6 removals and 4 posterior decompressions without removal of the device6 ACDF62.3% of patients had symptoms possibly related to adjacent level
Secure-C10 Surgeries at adjacent levels (4.2%)4 Posterior decompression
Lavelle et al. [25], 2019Prospective randomized singlecenter study242 PatientsSerious adverse effects 4.1% - 8 cases - 1 reported implant loosening, 1 mal-positioned implant, 1 excessive neck/ arm pain, and 5 spinal events (all the 8 at the index level with three requiring implant removal)3 ACDF
Bryan
Gornet et al. [26], 2019Prospective randomized multicenter study209 PatientsCumulative rate of secondary surgery was 4.7% (9 patients) at the index level (six removal, 2 supplemental fixation and 3 reoperation) and 9% at adjacent levels6 ACDFCumulative rate of serious adverse effects (grade 3 and 4) associated with implant were 3.8% patients through 10 years
Prestige LP2 Supplemental fixation
2-levels3 ReoperationRate of HO grade III and IV 39%
Dufour et al. [27], 2019Prospective cohort multicenter study384 Patients with 535 prostheses1.5% of reoperation at the index level – 6 of 384 – device removal or repositioning.Complication rates: 34 patients (8.9%) had 41 adverse events (device-surgery related with/ without reoperation)Grade 4 HO - 16.4% of the implanted segments had ossification with complete fusion; grade 3 in 6.8%, grade 2 in 39.4%, grade 1 in 14.4%, and grade 0 in 22.9%.
Mobi-C2.9% of surgery at adjacent levels – 11 patients – 4 for new symptomatic ALD and 7 had already an ADD minor before surgeryDistal and proximal adjacent degeneration occurred in 42.2% and 39.1% of patients.

HO, heterotopic ossification; ACDF, anterior cervical discectomy and fusion; ASD, adjacent segmental degeneration; ACCF, anterior corpectomy and fusion; PCF, posterior cervical fusion; TDR, total disc replacement; ADD, adjacent disc disease.

2. Reoperation at the Index Level

There were 161 patients who had at least 1 reoperation at the index level. The reoperation rate was 3.9% with a minimum 5-year of follow-up. Of note, these 161 patients had 170 surgeries, as some of them had one or more revision procedures.

3. Procedure for Reoperation the Index Level

In the majority of the studies, the procedure performed was not clearly described. When “removal” was mentioned in the studies, we inferred that an ACDF was performed after removal of the device. When reoperation/revision was mentioned, we inferred that the CDA was replaced by another implant or the patients had the implant repositioned, but a fusion was not performed, as many authors used the terms “removal” and “revision” in the same study with different meanings. When mentioned in the study results (90 patients), the revision procedures performed were: ACDF/removal: 61 (68%); supplemental fixation/posterior cervical fusion: 14 (15.5%); reoperation/revision: 12 (13.3%); posterior decompression/laminectomy: 2 (2.2%); anterior cervical corpectomy and fusion: 1 (1.1%). Of note, the levels of revision procedures included were not always mentioned, but some of them involved additional levels. Of note, Sasso et al. [22] did not have a revision surgery at the index surgery after the procedure, but 3 of the 242 patients who were planning to have a CDA required an intraoperative ACDF due to severe disc degeneration, small disc space, and inadequate visualization of the index level (C67). We considered this as a failure CDA at the index level.

4. Reasons for Reoperation at the Index Level

Interestingly, information about a patient’s outcome after revision surgery at the index level was rarely described in the included studies. An exception to this was Hacker et al. [10], who reported the outcomes of 3 patients: one had a Bryan disc subluxation and subtle findings of myelopathy and underwent an ACDF with a fair outcome. Another had local kyphosis after a Bryan disc and subsequently underwent a 2-level ACDF with a good outcome. Finally, a patient with a Prestige cervical disc had neck and arm pain, and loss of vertebral height and deformity. This patient required CDA removal and underwent a 2-level fusion, but the grafts subsided causing marked kyphosis requiring an additional procedure: a corpectomy and posterior fusion – with a fair outcome according to the authors. The following indications for revision surgeries at the index level were documented: progressive symptoms/ongoing neck or arm pain (the most common cause described), disc subluxation, segmental deformity, myelopathy after surgery, ossification causing pain and kyphosis, oversized implant, intraoperative fractures of the posterior vertebral wall, malpositioned implant [10,11,12,13,19,20,21].

DISCUSSION

In our review, we focused on high-quality studies discussing secondary surgery at the index level after a failed CDA. Most of the specific literature about CDA is about its safety and even superiority in clinical outcomes when compared with ACDF, as well as its potential to preserve motion. However, there is a paucity of data on the indications for reoperation, as well as the outcome of this group of patients, which are of paramount importance for patient counseling preoperatively. Park et al. [28] performed a retrospective evaluation of 21 patients who underwent a revision surgery after a CDA and had a minimum 2-year follow-up. In the primary procedure, 14 patients had a single level CDA, 2 patients had a 2-level CDA and 5 patients had 2-level hybrid surgery. The reasons for revision surgery were as follows: 17 (80.9%) were revised by poor patient selection according to them (such as severe cervical spondylosis or ossification of the posterior longitudinal ligament), 7 by insufficient decompression (35%), and 7 by implant malposition (35%), with 6 (28.5%) subsidences, 3 osteolysis (14.25%) and 1 postoperative infection (4.7%). To treat these failures, 16 patients had their CDA removed followed by 1-level ACDF (N = 11), 2-level ACDF (N = 3), 1-level corpectomy (N = 1), posterior laminoforaminotomy and fusion (N = 3), and combined procedures due to infection and osteolysis (N = 2). Using Odom’s scale, 86% of the patients were satisfied in the final follow-up. Similarly, with the results of our review, ACDF was the most commonly used salvage procedure following CDA failure, but it may include additional levels or supplementary posterior cervical surgery, increasing the morbidity of the procedure and potential complications. Interestingly, proper patient selection may decrease the reoperation rates. As stated in the study of Park et al. [5], CDA is not appropriate for all cases. Instead, CDA should be considered for those with preserved disc height, less severe degenerative disease, without spinal instability or deformities (such as kyphotic configuration of the segment) and osteoporosis [29]. The outcome of revisions procedures has rarely been studied. Only Hacker et al. [10] reported the outcomes, with fair results in 2 of 3 cases, requiring more complex salvage procedures. Additionally, the time for reoperation is quite variable in the literature. Zigler et al. [11] reported 30 (5.6%) reoperations in 535 patients who had a CDA using the ProDisc-C. The mean time for reoperation was 78.3 months, ranging from 24 to 181 months. They also reported no surgeries for device failure. In our review, the terms used in the studies were not also clear. For instance, some authors used the term “removal,” which we inferred that an ACDF was used instead. Revision or reoperation may be used interchangeably, for drainage a hematoma or to replace the CDA or even repositioning the implant. For this reason, a detailed analysis is limited. The U.S. Food & Drug Administration defines revision surgery as a procedure that adjusts or modifies the original implant configuration; removal surgery as a procedure that removes one or more components of the original implant and replacement by a different type of implant [30,31]. The misuse of these terms may lead to a wrong interpretation of the types of subsequent surgeries. The reoperation rate at the index level obtained in our review was 3.9%, with the most common salvage procedure being an ACDF (68%). Skovrlj et al. [31] discussed the options for a failed CDA. They proposed that, for infection, extrusion, malposition, subsidence, or retropulsion, the most reasonable option is to remove the implant and perform an ACDF. In cases where there is excessive bone removal of 1 or even 2 vertebral bodies, a 1- or 2-level corpectomy may be necessary, which may increase the morbidity of the procedure. Additionally, if by any reason a plate is not possible, posterior fixation may be also considered. For patients who had radiculopathy with foraminal stenosis, a posterior decompression (with or without fusion) is an option. Of note, salvage procedures increase the risk of complications and may be potentially associated with a less favorable outcome. In our review, we found reoperations for all the reasons reported by Skovrlj et al. with exception of infection. Our study is limited by the lack of specific and high-quality studies evaluating revision surgeries at the index level – the included studies did not focus on revision at the index level. The use of only PubMed database for searching clinical studies may reduce the number of included articles. Another limitation is the unclear use of the terms revision and removal in the studies, not always clear enough leading to potential bias in the interpretation of the types of subsequent surgeries. Finally, the heterogeneity in the data presentation and the low level of details, such as lack of final outcome for revision patients, may weaken our final interpretation. However, the results provide useful insight on CDA reoperations and the need for studies focusing on outcomes after revision CDA.

CONCLUSION

We report a reoperation rate of 3.9% after a long-term follow-up after a primary CDA. ACDF was the most common procedure to salvage a failed CDA. Some patients with CDA failure may require a more extensive salvage procedure and even subsequent surgeries. Future prospective studies addressing specifically the management and outcome of patients who failed a CDA are necessary.
  28 in total

1.  Prospective, randomized multicenter study of cervical arthroplasty versus anterior cervical discectomy and fusion: 5-year results with a metal-on-metal artificial disc.

Authors:  Domagoj Coric; Richard D Guyer; Pierce D Nunley; David Musante; Cameron Carmody; Charles Gordon; Carl Lauryssen; Margaret O Boltes; Donna D Ohnmeiss
Journal:  J Neurosurg Spine       Date:  2018-01-05

2.  Prospective, Randomized Comparison of One-level Mobi-C Cervical Total Disc Replacement vs. Anterior Cervical Discectomy and Fusion: Results at 5-year Follow-up.

Authors:  Michael S Hisey; Jack E Zigler; Robert Jackson; Pierce D Nunley; Hyun W Bae; Kee D Kim; Donna D Ohnmeiss
Journal:  Int J Spine Surg       Date:  2016-02-26

3.  Clinical and radiological evaluation of cervical disc arthroplasty with 5-year follow-up: a prospective study of 384 patients.

Authors:  T Dufour; J Beaurain; J Huppert; P Dam-Hieu; P Bernard; J P Steib
Journal:  Eur Spine J       Date:  2019-07-30       Impact factor: 3.134

4.  Clinical and radiographic analysis of an artificial cervical disc: 7-year follow-up from the Prestige prospective randomized controlled clinical trial: Clinical article.

Authors:  J Kenneth Burkus; Vincent C Traynelis; Regis W Haid; Praveen V Mummaneni
Journal:  J Neurosurg Spine       Date:  2014-07-18

5.  Five-year clinical results of cervical total disc replacement compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled, multicenter investigational device exemption clinical trial.

Authors:  Kris Radcliff; Domagoj Coric; Todd Albert
Journal:  J Neurosurg Spine       Date:  2016-03-25

6.  10-year follow-up after implantation of the Bryan Cervical Disc Prosthesis.

Authors:  Joost Dejaegher; Joris Walraevens; Johannes van Loon; Frank Van Calenbergh; Philippe Demaerel; Jan Goffin
Journal:  Eur Spine J       Date:  2016-11-30       Impact factor: 3.134

7.  Long-term clinical and radiographic outcomes of the Prestige LP artificial cervical disc replacement at 2 levels: results from a prospective randomized controlled clinical trial.

Authors:  Todd H Lanman; J Kenneth Burkus; Randall G Dryer; Matthew F Gornet; Jeffrey McConnell; Scott D Hodges
Journal:  J Neurosurg Spine       Date:  2017-04-07

8.  Long-term Clinical Outcomes of Cervical Disc Arthroplasty: A Prospective, Randomized, Controlled Trial.

Authors:  Willa R Sasso; Joseph D Smucker; Maria P Sasso; Rick C Sasso
Journal:  Spine (Phila Pa 1976)       Date:  2017-02-15       Impact factor: 3.468

9.  Long-Term Clinical Experience with Selectively Constrained SECURE-C Cervical Artificial Disc for 1-Level Cervical Disc Disease: Results from Seven-Year Follow-Up of a Prospective, Randomized, Controlled Investigational Device Exemption Clinical Trial.

Authors:  Alexander Vaccaro; William Beutler; Walter Peppelman; Joseph Marzluff; Andrew Mugglin; Prem S Ramakrishnan; Jacqueline Myer; Kelly J Baker
Journal:  Int J Spine Surg       Date:  2018-08-15

Review 10.  Comparison of cervical disc arthroplasty and anterior cervical discectomy and fusion for the treatment of cervical disc degenerative diseases on the basis of more than 60 months of follow-up: a systematic review and meta-analysis.

Authors:  Yijian Zhang; Nanning Lv; Fan He; Bin Pi; Hao Liu; Angela Carley Chen; Huilin Yang; Mingming Liu; Xuesong Zhu
Journal:  BMC Neurol       Date:  2020-04-20       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.